Recent studies have shown that melatonin directly binds to and inhibits the function of death-associated protein kinase 1 (DAPK1) in AD, thereby reducing the accumulation and phosphorylation of tau protein and promoting synaptic growth and microtubule assembly (Chen et al., 2020). The gene discussed is MAPT; the disease is Alzheimer disease.